News About: Goverment
Medical institutions to benefit from drug savings
Hospitals and clinics that save drug costs will enjoy more benefits, following the passage of a bill to allow an incentive to medical institutions in favor of low-priced drugs in the lawmakers' Committee for Health & ...
Prices of 4 original brands to be reduced by 20% next month
As generic drugs get listed for insurance coverage, the prices of the corresponding four original medicines will be decreased by 20 percent from this February 1, the Ministry of Health and Welfare said on January 24.
...
Wholesalers urged to upgrade drug logistics system
The domestic wholesaling industry should push for the modernization of drug logistics system via full utilization of a large joint distribution center or warehouse, including strict observance of fair trade code and e...
KFDA warns use of cold remedies in infants
Parents who have children under two years old will be obliged to consult a pediatrician and get a prescription for the commonly used cold medicine for their children, according to the Korea Food and Drug Administratio...
150 billion won set aside for research in 2008
The Ministry of Health and Welfare said on January 22 that it has allocated 144.7 billion won for research and development (R&D) of new drugs in 2008, up 38.4 percent from the previous year, in a recently held consult...
Government to disclose overprescribing hospitals
The government plans to make public a list of hospitals and clinics overprescribing drugs to reduce unnecessary pill prescriptions in medical institutions, officials at the Health Insurance Review & Assessment Ser...
Korea's R&D spending to exceed 10 trillion won this year
The Ministry of Science and Technology says that the government is planning to spend around 10.8 trillion won on state-funded R& D projects this year, which is more than double the amount it spent in 2001, and a 10-pe...
Drug-related administration to be reformed
The Korea Food and Drug Administration says it is contemplating a series of new measures designed to ameliorate pharmaceuticals-related regulations.
Under its new plan, any venture firm will be allowed to obtain a ...
KFDA approves 9 clinical trials
The Korea Food and Drug Administration said it gave a green light for clinical trials for nine drugs, including Daehwa's anticancer agent DHP107 (paclitaxel) and GlaxoSmithKline's Tykerb (lapatinib).
Tykerb, an exp...
Health Ministry hopes to integrate R&D functions for new drugs
As the functions of the Ministry of Science and Technology would be split between the Ministry of Commerce, Industry and Energy, and the Ministry of Education and Human Resources Development, the Health and Welfare Mi...
